Home National Bharat Biotech appeals to the Government for emergency use of Covaxin

Bharat Biotech appeals to the Government for emergency use of Covaxin

168
0

The first clinical trial report of India’s own coronavirus vaccine Covaxin has been released. The report has reassured the public, including vaccine maker Bharat Biotech. According to the company, the first clinical trial showed that the vaccine developed antibodies in the body, but did not show any side effects.

Bharat Biotech appeals to the Government for emergency use of Covaxin 1
Image Source : Google

“Any side effects that have been shown to the people have also been cured very quickly without any medication,” company officials said. Similarly, the pain caused by vaccination in the body has also been automatically cured. Now Covaxin, along with two other vaccines, has appealed to the government for emergency use.

Bharat Biotech appeals to the Government for emergency use of Covaxin 2
Image Source : Google

A few days ago, Suchitra Ella, Joint Director, Bharat Biotech, India, hoped that Covaxin would be available in the country in the first three months of 2021 with safety and power. She also hoped that the government’s vaccination program in the country would provide first-class Covaxin.

How useful was this post?

Click on a star to rate it!

Average rating 5 / 5. Vote count: 3

No votes so far! Be the first to rate this post.

🤞 Don’t miss Daily News!

We don’t spam! Read our privacy policy for more info.

LEAVE A REPLY

Please enter your comment!
Please enter your name here